Sun, Apr 20, 2014, 6:18 PM EDT - U.S. Markets closed


% | $
Quotes you view appear here for quick access.

Amylin Pharmaceuticals, Inc. Message Board

  • kevinmik kevinmik Feb 5, 2012 11:24 AM Flag

    Bydureon & Byetta Will Overtake Victoza This Year !

    The approximate past 8 week average sales for Byetta was 28,000 and Victoza 33,000. I believe Exenatide (Byetta + Bydureon) weekly scripts will overtake Victoza by the 3Q 2012 and when Bydureon Pen hits the marketplace, we will see Exenatide (Byetta + Bydureon) start to capture some of the oral drugs marketshare that will begin to erode. I am hoping to see Exenatide (Byetta + Bydureon) weekly scripts break the 40,000 + mark this year.


    SortNewest  |  Oldest  |  Most Replied Expand all replies

Trending Tickers

Trending Tickers features significant U.S. stocks showing the most dramatic increase in user interest in Yahoo Finance in the previous hour over historic norms. The list is limited to those equities which trade at least 100,000 shares on an average day and have a market cap of more than $300 million.